Taiwan FDA registration 292095ad9a4175e09cffbd2b83f91eeb
Abbott "Mayris" hepatitis C virus antibody test reagent (4th generation)
TW: 亞培”妙芮絲”C型肝炎病毒抗體檢驗試劑(第四代)
Taiwan·Risk Class 3·DiaSorin South Africa (Pty) Ltd.·Registered Aug 08, 2005 – Aug 12, 2022CancelledRegistration details
- Analysis ID
- 292095ad9a4175e09cffbd2b83f91eeb
- Customs Code
- DHA00601174100
Company information
- Manufacturer
- DiaSorin South Africa (Pty) Ltd.
- Manufacturer Country
- South Africa
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- Enzyme immunoassay is used to test human serum or plasma for antibodies to hepatitis C virus.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Import Information
- import
Dates and status
- Registration Date
- Aug 08, 2005
- Expiry Date
- Aug 12, 2022
- Cancellation Date
- Apr 18, 2022
Cancellation information
- Status
- Logged out
- Reason
- 自請註銷
About this record
Access comprehensive regulatory information for Abbott "Mayris" hepatitis C virus antibody test reagent (4th generation) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 292095ad9a4175e09cffbd2b83f91eeb and manufactured by DiaSorin South Africa (Pty) Ltd.. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices